Concomitant Immunity against Tumor Development is Enhanced by the Oral Administration of a Kampo Medicine, Hochu-Ekki-To (TJ-41: BU-ZHONG-YI-QI-TANG)

References

• Kumazawa Y., Takimoto H., Miura S., Nishimura C., Yamada A., Kawakita T., Nomoto K. Activation of murine peritoneal macrophage by intraperitoneal administration of traditional Chinese herbal medicine, xiao-chai-hu-tang (Japanese name: shosaiko-to). Int. J. Immunopharmac. 1988; 10: 395
   PubMed Web of Science ®Google Scholar
• Kawakita T., Yamada A., Mitsuyama M., Kumazawa Y., Nomoto K. Protective effect of a traditional Chinese medicine, xiao-chai-hu-tang (Japanese name: shosaiko-to), on Psuedomonas aeruginosa infection in mice. Immunopharm. Immunotox. 1987; 9: 523
   PubMed Web of Science ®Google Scholar
• Kawakita T., Yamada A., Mitsuyama M., Kumazawa Y., Nomoto K. Protective effect of a traditional Chinese medicine, xiao-chai-hu-tang (Japanese name: shosaiko-to), on Listeria monocytogenes infection in mice. Immunopharm. Immunotox. 1988; 10: 345
   PubMed Web of Science ®Google Scholar
• Li X., Takimoto H., Miura S., Yoshikai Y., Matsuzaki G., Nomoto K. Effect of a traditional Chinese medicine, bu-zhong-yi-qi-tang (Japanese name: hochu-ekki-to) on the protection against Listeria monocytogenes infection in mice. Immunopharm. Immunotox. 1992; 14: 383
   PubMed Web of Science ®Google Scholar
• Aburada M., Takeda S., Ito E., Nakamura M., Hosoya E. Protective effects of Juzentaihoto, dried decoctum of 10 Chinese herbs mixture, upon the adverse effects of Mitomycin C in mice. J. Pharm. Dyn. 1983; 6: 1000
   PubMedGoogle Scholar
• Miura S., Kawamura I., Yamada A., Kawakita T., Kumazawa Y., Himeno K., Nomoto K. Effect of a traditional Chinese herbal medicine, ren-sheng-yang-rong-tang (Japanese name: ninjin-youei-to) on hematopoietic stem cells in mice. Int. J. Immunopharmac. 1989; 11: 771
   PubMed Web of Science ®Google Scholar
• Haranaka K., Satomi N., Sakurai A., Haranaka R., Okada N., Kobayashi M. Antitumor activity and tumor necrosis factor productivity of traditional Chinese medicines and crude drugs. Cancer Immunol. Immunother. 1985; 20: 1
   PubMed Web of Science ®Google Scholar
• Hamada M., Fujii Y., Yamamoto H., Miyazawa Y., Shui S. M., Tung Y. C., Yamaguchi N. Effect of a kampo medicine, zyuzentaiho-to, on the immune reactivity of tumor-bearing mice. J. Ethnopharmac. 1988; 24: 311
   PubMedGoogle Scholar
• Haranaka R., Hasegawa R., Nakagawa S., Sakumi A., Satomi N., Haranaka K. Antitumor activity of combination therapy with traditional Chinese medicine and OK432 or MMC. J. Biol. Response Modif. 1988; 7: 77
   PubMedGoogle Scholar
• Cho J., Sato N., Kikuchi K. Prophylactic anti-tumor effect of hochu-ekki-to (TJ-41) by enhancing natural killer cell activity. In Vivo 1991; 5: 389
   PubMedGoogle Scholar
• Kaneko M., Kawakita T., Tauchi Y., Saito T., Suzuki A., Nomoto K. Augmentation of NK activity after oral administration of a traditional Chinese medicine, xiao-chai-hu-tang (shosaiko-to). Immunopharm. Immunotox. 1994; 16: 41
   PubMed Web of Science ®Google Scholar
• Kawakita T., Nakai S., Kumazawa Y., Miura O., Yumioka E., Nomoto K. Induction of interferon after administration of a traditional Chinese medicine, xiao-chai-hu-tang (shosaiko-to) Int. J. Immunopharmac. 1990; 12: 515
   Google Scholar
• Matsomoto T., Himeno K., Mitani M., Mori M., Mori K., Miake S., Nomoto K. Differing contribution of various effector cells in the elimination of syngeneic or allogeneic cells. J. Clin. Lab. Immunol. 1986; 19: 83
   PubMedGoogle Scholar
• Winn H. J. Immune mechanisms in homotransplantation. II. Quantitative assay of the immunologic activity of lymphoid cells stimulated by tumor homograft. J. Immunol. 1961; 86: 228
   PubMed Web of Science ®Google Scholar
• Yoshizawa H., Chang A. E., Shu S. Specific adoptive immunotherapy mediated by tumor-draining lymph node cells sequentially activated with anti-CD3 and IL-2. J. Immunol. 1991; 147: 729
   PubMed Web of Science ®Google Scholar
• Okamoto T., Harada M., Shinomiya Y., Matsuzaki G., Nomoto K. The antitumor effect of tumor-draining lymph node cells activated by both anti-CD3 monoclonal antibody and activated B cells as costimulatory signal-providing cells. Caner Immunol. Immunother. 1995, in press
   Google Scholar
• Mitani M., Mori K., Himeno K., Matsumoto Y., Taniguchi K., Nomoto K. The role of cytostasis in antitumor immunity: Comparison between syngeneic and allogeneic systems. Cell. Immunol. 1985; 92: 22
   PubMedGoogle Scholar
• Mosmann T. R., Schumacher J. H., Street N. F., Budd R., O'garra A., Fong T. AT., Bond M. W., Moore K. W. M., Sher A., Fiorentino D. F. Diversity of cytokine synthesis and function of mouse CD4+ T cells. Immunol. Rev. 1991; 123: 209
   PubMed Web of Science ®Google Scholar
• Nagarkatti M., Clary S. R., Nagarkatti P. S. Characterization of tumor-infiltrating CD4+ T cells as Th1 cells based on lymphokine secretion and functional properties. J. Immunol. 1990; 144: 4898
   PubMed Web of Science ®Google Scholar
• Harada M., Matsuzaki G., Yoshikai Y., Kobayashi N., Kurosawa S., Takimoto H., Nomoto K. Autoreactive and heat shock protein 60-recognizing CD4+ T cells show antitumor activity against syngeneic fibrosarcoma. Cancer Res. 1993; 53: 106
   PubMedGoogle Scholar
• North R. J., Bursuker I. Generation and decay of the immune response to a progressive fibrosarcoma. I. Ly 1+2− suppressor T cells down-regulate the generation of Ly-1−2+ effector T cells. J. Exp. Med. 1984; 159: 1295
   PubMed Web of Science ®Google Scholar